Answer
Adjuvanted Trivalent Influenza Vaccine Seqirus is indicated for influenza prevention in adults aged 50 years and older and should be used in accordance with official recommendations.
Sources for this answer
- adjuvanted Trivalent Influenza VaccineSeqirus UK Limited · emc · SmPC §4.1 Therapeutic Indications · Version 4Document updated
Sources checked